XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 6 Months Ended 9 Months Ended
Aug. 06, 2021
Jun. 11, 2021
Dec. 31, 2017
Jun. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Common stock, shares issued         42,721,566   42,721,566
Fair value of common stock on grant date (in dollars per share)         $ 3.13    
Total intrinsic value of the stock options exercised         $ 0.0 $ 0.9  
Dividend yield (as a percent)         0.00%    
Employee Stock Option              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Fair value of common stock on grant date (in dollars per share)         $ 1.83 $ 1.62  
Dividend yield (as a percent)         0.00% 0.00%  
Restricted Stock Units              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Vesting percentage         25.00%    
Vesting period of PRSUs after acceptance         4 years    
Description of vesting rights         RSUs awarded to employees generally vest one-fourth per year over four years from the anniversary of the date of grant    
Performance Based Restricted Stock Units              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Shares issued 3,813,150            
Total unrecognized compensation costs         $ 4.5    
Weighted-average period over which unrecognized compensation costs is expected to be recognized         1 year 7 months 6 days    
Granted (in shares) 3,813,150            
Stock Option Awards [Member]              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Cancellation of company's common stock         7,631,844    
Total unrecognized compensation costs         $ 1.5    
Weighted-average period over which unrecognized compensation costs is expected to be recognized         1 year 2 months 12 days    
Option Exchange Program [Member]              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Non-cash incremental stock-based compensation cost         $ 0.5    
Common stock, shares issued 7,631,844            
Common stock exchanged for PRSUs 3,813,150            
Option Exchange Program [Member] | Performance Based Restricted Stock Units              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Exercise price per unit   $ 4.47          
Vesting percentage   50.00%          
Option Exchange Program [Member] | Performance Based Restricted Stock Units | U S Food and Drug Administration [Member] | Minimum [Member]              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Vesting period of PRSUs after acceptance   3 years          
Option Exchange Program [Member] | Performance Based Restricted Stock Units | U S Food and Drug Administration [Member] | Maximum [Member]              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Vesting period of PRSUs after acceptance   5 years          
2013 Equity Incentive Plan | Common Stock              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Increase in number of shares authorized for issuance       2,000,000      
2013 Equity Incentive Plan | Employee Stock Option | Common Stock | Rick Russell              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Shares issued     775,000        
Granted (in shares)     775,000        
2013 Equity Incentive Plan | Restricted Stock Units | Common Stock | Rick Russell              
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]              
Shares issued     40,000        
Granted (in shares)     40,000